Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,499,975 papers from all fields of science
Search
Sign In
Create Free Account
Inhalant Solution
Known as:
Inhalation Solutions
, Inhalant Solution [Dose Form]
, Inhalant Solution Dosage Form
Expand
Liquid medication intended to be inhaled.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
35 relations
Acetylcysteine 200 MG/ML Inhalant Solution
Albuterol 0.833 MG/ML / Ipratropium Bromide 0.167 MG/ML Inhalant Solution
Aztreonam 75 MG/ML Inhalant Solution [Cayston]
Aztreonam Inhalant Solution [Cayston]
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Evidence for the efficacy of aztreonam for inhalation solution in the management of Pseudomonas aeruginosa in patients with cystic fibrosis
C. Hansen
,
M. Skov
Therapeutic Advances in Respiratory Disease
2015
Corpus ID: 22988276
Chronic airway infection in cystic fibrosis (CF) is a main cause of the increased morbidity and mortality found with this disease…
Expand
2014
2014
ANALYSIS OF LONG-TERM LIPOSOMAL AMIKACIN FOR INHALATION IN PATIENTS WITH CYSTIC FIBROSIS AND CHRONIC INFECTION FROM PSEUDOMONAS AERUGINOSA
D. Bilton
,
T. Pressler
,
+11 authors
M. Konstan
2014
Corpus ID: 79401610
INTRODUCTION • Liposomal amikacin for inhalation (LAI) is a novel formulation of amikacin currently in development for the…
Expand
2012
2012
The budesonide joint compound ipratropium bromide solution inhalation in the treatment of children with bronchiolitis
Cheng Shunmao
2012
Corpus ID: 75649826
Objective To explore budesonide joint compound ipratropium bromide solution inhalation treatment of children with bronchiolitis…
Expand
2010
2010
ELITE trial infection in patients with cystic fibrosis: the Pseudomonas aeruginosa Treatment of early
F. Ratjen
,
A. Munck
,
P. Kho
2010
Corpus ID: 76940979
Rationale Antibiotic therapy for early Pseudomonas aeruginosa infection in patients with cystic fibrosis (CF) is effective, but…
Expand
Review
2010
Review
2010
Aztreonam for inhalation solution (Cayston) for cystic fibrosis.
The Medical letter on drugs and therapeutics
2010
Corpus ID: 11596696
2008
2008
[Microorganisms in home-care inhalation devices].
M. Exner
,
F. Vogel
,
H. Rost
Deutsche Medizinische Wochenschrift
2008
Corpus ID: 34306259
Contamination of inhalation equipment used at home, cleaning procedures, and the occurrence of potentially pathogenic micro…
Expand
1983
1983
Mikroorganismen in Inhalationsgeräten der Heimtherapie
M. Exner
,
F. Vogel
,
H. Rost
1983
Corpus ID: 260127237
1979
1979
Inhibition of exercise-induced bronchoconstriction by nebulised sodium cromoglycate in patients with bronchial asthma.
R. Dahl
,
J. Henriksen
Scandinavian journal of respiratory diseases
1979
Corpus ID: 36373452
In this double blind study, 10 patients with bronchial asthma underwent exercise challenge on five occasions. The first of these…
Expand
1979
1979
Dose response relationship of clenbuterol (NAB 365) as a solution for inhalation
M. Tschan
,
A. Perruchoud
,
H. Herzog
European Journal of Clinical Pharmacology
1979
Corpus ID: 23549469
SummaryThe dose-response relationship of the new bronchodilator Clenbuterol (NAB 365, Boehringer Ingelheim) was tested in 12…
Expand
1978
1978
[The bronchospasmolytics salbutamol, fenoterol, terbutaline and reproterol. Their effects and side effects in asthmatics after inhalation with an electric nebulizer].
H. Budmiger
,
K. Kyd
,
M. Scherrer
Swiss medical weekly
1978
Corpus ID: 26016458
A double-blind crossover trial was conducted in 10 asthmatic patients for comparison of fenoterol with salbutamol, in 12 other…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE